Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -22521.52% is 9754% below its 5-year average of -228.56%, near the high end of its 5-year range (-53978075186435344.00%–0.00%).
35.26% below its 12-month average of -16650.25%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -19978.57%.
NET PROFIT MARGIN
-22521.52%
NET PROFIT MARGIN AVG TTM
-16650.25%
NET PROFIT MARGIN AVG 3Y
-6937.61%
NET PROFIT MARGIN AVG 5Y
-228.56%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-35.26%
CURRENT VS 3Y AVG
-224.63%
CURRENT VS 5Y AVG
-9753.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-8662023.08%
vs the sector median at left
PRF Technologies Ltd.
Market Cap
$71110.00
Net Profit Margin
-22521.52%
TTM Avg
-16650.25%
3Y Avg
-6937.61%
5Y Avg
-228.56%
Market Cap
$61495.00
Net Profit Margin
-17690.19%
TTM Avg
-9089.88%
3Y Avg
-5029.73%
5Y Avg
-25219.12%
Market Cap
$97282.00
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$109358.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$31778.00
Net Profit Margin
-55.47%
TTM Avg
-29.76%
3Y Avg
-34.66%
5Y Avg
-18.73%
Market Cap
$30504.00
Net Profit Margin
-44.25%
TTM Avg
-77.97%
3Y Avg
-46.13%
5Y Avg
-41.70%
Market Cap
$6128.00
Net Profit Margin
N/A
TTM Avg
99.68%
3Y Avg
52.40%
5Y Avg
41.92%
Market Cap
$242924.00
Net Profit Margin
-1422.78%
TTM Avg
-951.97%
3Y Avg
-568.57%
5Y Avg
-575.76%
Market Cap
$381940.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-352.76%
5Y Avg
-376.69%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PRF Technologies Ltd. (PRFX) | $71110.00 | -22521.52% | -16650.25% | -6937.61% | -228.56% |
| Akanda Corp. (AKAN)vs › | $61495.00 | -17690.19% | -9089.88% | -5029.73% | -25219.12% |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | N/A | 0.00% | 0.00% | 0.00% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109358.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Zhongchao Inc. (ZCMD)vs › | $31778.00 | -55.47% | -29.76% | -34.66% | -18.73% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30504.00 | -44.25% | -77.97% | -46.13% | -41.70% |
| NewGenIvf Group Limited (NIVF)vs › | $6128.00 | N/A | 99.68% | 52.40% | 41.92% |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | -1422.78% | -951.97% | -568.57% | -575.76% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | 0.00% | 0.00% | -352.76% | -376.69% |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | -40439.10% | -68089.13% | -51057.85% | -34126.19% |
Operating Margin
-29335.3%
Net Profit Margin
-22521.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -19978.57% |
| 2026-03-31 | -19978.57% |
| 2025-12-31 | -28458.82% |
| 2025-09-30 | -14835.29% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -53978075186435344.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -3656.98% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
